Mucormycosis Clinical Trial
Official title:
Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children
The goal of this clinical trial is to learn the plasma concentration of isavuconazole in pediatric patients. It will also learn about the relationship of isavuconazole plasma concentrations to efficacy and safety in pediatric patients. The main questions it aims to answer are: What is the plasma concentration after using isavuconazole in pediatric patients? What is the effective range of plasma concentration of isavuconazole in pediatric patients? What is the safe range of plasma concentration of isavuconazole in pediatric patients? Researchers will measure the plasma concentration of isavuconazole to see whether it is appropriate. Participants will: Take drug isavuconazole as prescribed by the doctor; 1mL of blood is drawn 30min before the next dose.
Objectives of Study: Main objective: To monitor the plasma concentration of isavuconazole in children, and to study the pharmacokinetic characteristics of isavuconazole in children, so as to provide basis for the optimization of individualized drug administration. Secondary objective: To evaluate the relevance of isavuconazole plasma concentrations to efficacy and safety in pediatric patients. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03387696 -
Mucormycosis in ICU
|
||
| Recruiting |
NCT04744454 -
Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
|
||
| Completed |
NCT00419770 -
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
|
Phase 2 | |
| Recruiting |
NCT05925660 -
Mucorales PCR Screening in At-risk Hematology Patients
|
N/A | |
| Completed |
NCT04935463 -
Mucormycosis in COVID-19
|
||
| Completed |
NCT04550936 -
Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis
|
||
| Completed |
NCT05074043 -
COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
|
||
| Not yet recruiting |
NCT05406037 -
Biomarkers for Invasive Mucormycosis
|
||
| Completed |
NCT02845934 -
Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
|
N/A | |
| Completed |
NCT05348434 -
Evaluation of Using 3D Printed PEEK Facial Implants in Repairing Maxillofacial Deformities
|
||
| Completed |
NCT05212961 -
COVID-19 and Rhino-orbital Mucormycosis
|
||
| Recruiting |
NCT05097664 -
Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran
|